{"id":818,"date":"2017-11-20T15:53:22","date_gmt":"2017-11-20T15:53:22","guid":{"rendered":"http:\/\/rheum.ca\/?page_id=818"},"modified":"2023-09-11T18:01:04","modified_gmt":"2023-09-11T18:01:04","slug":"recommandations-canadiennes-pour-la-prise-en-charge-de-la-pr","status":"publish","type":"page","link":"https:\/\/rheum.ca\/fr\/resources\/publications\/recommandations-canadiennes-pour-la-prise-en-charge-de-la-pr\/","title":{"rendered":"Recommandations canadiennes pour la prise en charge de la PR"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h1>Recommandations canadiennes pour la prise en charge de la PR<\/h1>\n<p><strong>Les Lignes directrices \u00e9volutives sur la prise en charge pharmacologique de la PR par des antirhumatismaux modificateurs de la maladie (ARMM), nouvellement mises \u00e0 jour, ont paru sur MAGICapp <a href=\"https:\/\/app.magicapp.org\/#\/guideline\/7388\">ici<\/a>.<\/strong><\/p>\n<p>La SCR pr\u00e9sente la mise \u00e0 jour 2011-2012 de ses Recommandations pour le traitement pharmacologique de la PR, qui tient compte de l&#8217;\u00e9tat actuel du syst\u00e8me de sant\u00e9 canadien. Les recommandations r\u00e9pondent aussi \u00e0 des questions soulev\u00e9es lors d\u2019une \u00e9valuation nationale des besoins men\u00e9e aupr\u00e8s des rhumatologues canadiens. Elles sont publi\u00e9es en deux parties.<\/p>\n<h2>Points saillants des Recommandations 2011- 2012 de la SCR pour la PR<\/h2>\n<h3>Partie 1 : Recommandations portant sur le traitement de la PR<\/h3>\n<ul>\n<li>Cinq grands principes qui sous-tendent le traitement de la PR<\/li>\n<li>Vingt-six (26) recommandations th\u00e9rapeutiques correspondant \u00e0 des strat\u00e9gies g\u00e9n\u00e9rales pour la prise en charge de la PR et \u00e0 des strat\u00e9gies sp\u00e9cifiques concernant la corticoth\u00e9rapie et les ARMM classiques et biologiques<\/li>\n<li>\u00c9valuation sommaire de la PR et algorithmes th\u00e9rapeutiques<\/li>\n<\/ul>\n<h3>Partie 2 : Recommandations portant sur la s\u00e9curit\u00e9 dans la PR<\/h3>\n<p>Treize recommandations sur les aspects sp\u00e9cifiques concernant l\u2019innocuit\u00e9 des ARMM classiques et des agents biologiques, y compris :<\/p>\n<ul>\n<li>Prise en charge p\u00e9riop\u00e9ratoire<\/li>\n<li>D\u00e9pistage d\u2019une tuberculose latente, indications de l\u2019instauration d\u2019un traitement antituberculeux prophylactique<\/li>\n<li>Pratiques vaccinales optimales<\/li>\n<li>Prise en charge des patients qui souffrent ou ont souffert de cancer<\/li>\n<\/ul>\n<p>Recommandations regroup\u00e9es en tableaux\/listes de v\u00e9rification faciles \u00e0 utiliser<\/p>\n<h3><strong>\u00c0 T\u00e9l\u00e9charger<\/strong><\/h3>\n<p><strong>Publications du Journal of Rheumatology<\/strong><\/p>\n<p><a href=\"http:\/\/jrheum.org\/content\/39\/8\/1497.full.pdf+html\" target=\"_blank\" rel=\"noopener noreferrer\">Editorial overview of 2011\/2012 CRA Recommendation for RA<\/a><\/p>\n<p><a href=\"http:\/\/jrheum.org\/content\/39\/8\/1559.full.pdf+html\" target=\"_blank\" rel=\"noopener noreferrer\">Part 1: 2011\/2012 CRA Treatment Recommendations for RA<\/a><\/p>\n<p><a href=\"http:\/\/jrheum.org\/content\/39\/8\/1583.full.pdf+html\" target=\"_blank\" rel=\"noopener noreferrer\">Part 2: 2011\/2012 CRA Safety Recommendations for RA\u00a0<\/a><\/p>\n<p><a href=\"https:\/\/rheum.ca\/wp-content\/uploads\/2021\/06\/Pre-Guideline-National-Needs-Assessment-Results.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Pre-Guideline National Needs Assessment Results<\/a><\/p>\n<p><a href=\"https:\/\/rheum.ca\/wp-content\/uploads\/2021\/06\/supporting_information_Rheumatology.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Supporting Information<\/a><\/p>\n<h3><strong>Outils<\/strong><\/h3>\n<p><a href=\"http:\/\/jrheum.org\/content\/39\/8\/1559.figures-only\" target=\"_blank\" rel=\"noopener noreferrer\">2011\/2012 RA Treatment &amp; Assessment Algorithms<\/a><\/p>\n<p><a href=\"https:\/\/rheum.ca\/wp-content\/uploads\/2021\/03\/CRA-RA-Guidelines-Part-1-Treatment.pdf\">CRA RA Guidelines Part 1 Treatment<\/a><\/p>\n<p><a href=\"https:\/\/rheum.ca\/wp-content\/uploads\/2021\/05\/2012_CRA-Recommendations-for-RA_Part-2-Safety-1.pptx\">2012_CRA Recommendations for RA_Part 2 Safety<\/a><\/p>\n<p>Questions et \/ ou des commentaires au sujet de ces recommandations peuvent \u00eatre envoy\u00e9s \u00e0\u00a0<a href=\"mailto:raguidelines@rheum.ca\">raguidelines@rheum.ca<\/a><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":10,"featured_media":0,"parent":802,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/pages\/818"}],"collection":[{"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/comments?post=818"}],"version-history":[{"count":3,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/pages\/818\/revisions"}],"predecessor-version":[{"id":17615,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/pages\/818\/revisions\/17615"}],"up":[{"embeddable":true,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/pages\/802"}],"wp:attachment":[{"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/media?parent=818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/categories?post=818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rheum.ca\/fr\/wp-json\/wp\/v2\/tags?post=818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}